about
Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stim...
Read More
0.45
0.02
(4.65%)
468.8K
XNAS Volume
XNAS 08 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Immutep Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..